XOMA Royalty (XOMA) Total Current Liabilities (2010 - 2026)

XOMA Royalty (XOMA) reported Total Current Liabilities of $33.1 million for Q1 2026, up 61.87% on a YoY basis from $20.4 million in Q1 2025, and down 5.01% sequentially from $34.8 million in Q4 2025.

XOMA Royalty (XOMA) Total Current Liabilities (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Total Current Liabilities data on file, last reported at $33.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities rose 61.87% year-over-year to $33.1 million; the trailing twelve-month figure through Mar 2026 stood at $33.1 million (up 61.87% YoY), and the FY2025 full-year result was $34.8 million, up 42.86% from the prior year.
  • Total Current Liabilities eased to $33.1 million in Q1 2026, from $34.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $34.8 million in Q4 2025 to a low of $5.4 million in Q3 2022.
  • A 5-year average of $16.6 million and a median of $17.1 million in 2024 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities plunged 47.42% in 2022 and jumped 185.99% in 2023, its largest moves.
  • Tracing XOMA's Total Current Liabilities over 5 years: stood at $6.8 million in 2022, then jumped by 185.99% to $19.5 million in 2023, then climbed by 25.0% to $24.4 million in 2024, then jumped by 42.86% to $34.8 million in 2025, then retreated by 5.01% to $33.1 million in 2026.
  • Business Quant data shows XOMA's Total Current Liabilities at $33.1 million in Q1 2026, $34.8 million in Q4 2025, and $21.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 33.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.08 Mn
Dec 31, 2025 34.82 Mn
Jun 30, 2025 21.50 Mn
Mar 31, 2025 20.43 Mn
Dec 31, 2024 24.37 Mn
Sep 30, 2024 21.13 Mn
Jun 30, 2024 18.62 Mn
Mar 31, 2024 15.54 Mn
Dec 31, 2023 19.50 Mn
Sep 30, 2023 10.33 Mn
Jun 30, 2023 7.09 Mn
Mar 31, 2023 10.09 Mn
Dec 31, 2022 6.82 Mn
Sep 30, 2022 5.43 Mn
Jun 30, 2022 8.42 Mn
Mar 31, 2022 7.89 Mn
Dec 31, 2021 12.97 Mn
Sep 30, 2021 6.51 Mn
Jun 30, 2021 6.29 Mn
Mar 31, 2021 13.11 Mn